|
CARD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08450000044525E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22679999999364E-05 |
| Normal-vs-Stage2 |
1.50566000000074E-05 |
| Normal-vs-Stage3 |
1.05340000056131E-08 |
| Normal-vs-Stage4 |
3.5627000238847E-09 |
| Stage1-vs-Stage2 |
3.654800E-01 |
| Stage1-vs-Stage3 |
4.364100E-04 |
| Stage1-vs-Stage4 |
5.371100E-04 |
| Stage2-vs-Stage3 |
6.277600E-02 |
| Stage2-vs-Stage4 |
1.099560E-02 |
| Stage3-vs-Stage4 |
2.932600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18149999953177E-07 |
| Normal-vs-AfricanAmerican |
4.45089999999704E-05 |
| Normal-vs-Asian |
1.644630E-04 |
| Caucasian-vs-AfricanAmerican |
9.577200E-01 |
| Caucasian-vs-Asian |
2.258000E-01 |
| AfricanAmerican-vs-Asian |
4.484800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55980000005052E-06 |
| Normal-vs-Female |
2.11619999967994E-07 |
| Male-vs-Female |
2.282000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.99950000000194E-05 |
| Normal-vs-Age(41-60Yrs) |
8.4425999968829E-08 |
| Normal-vs-Age(61-80Yrs) |
7.79480000545618E-08 |
| Normal-vs-Age(81-100Yrs) |
1.032450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.517600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.199700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.470400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.996400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.827000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.555600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.368200E-04 |
| Classical-VS-Follicular |
9.475800E-02 |
| Classical-VS-Other |
7.167600E-01 |
| Classical-VS-Normal |
1.15259999999839E-06 |
| Tall-VS-Follicular |
4.61259999995356E-06 |
| Tall-VS-Other |
2.180500E-02 |
| Tall-VS-Normal |
1.5928003360699E-10 |
| Follicular-VS-Other |
8.140600E-01 |
| Follicular-VS-Normal |
2.379100E-04 |
| Other-VS-Normal |
8.002500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89190000002382E-06 |
| Normal-vs-N1 |
4.90329999935923E-08 |
| N0-vs-N1 |
2.629900E-02 |
|
|
